ADMA BIOLOGICS, INC. Increase (Decrease) in Deferred Liabilities
ADMA BIOLOGICS, INC. (ADMA) reported Increase (Decrease) in Deferred Liabilities of -$7.64 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLiabilities · last filed 2017-05-12
- ADMA BIOLOGICS, INC. increase (decrease) in deferred liabilities for the quarter ending 2017-03-31 was -$7.64K.
- ADMA BIOLOGICS, INC. increase (decrease) in deferred liabilities for the quarter ending 2016-12-31 was -$7.64K.
- ADMA BIOLOGICS, INC. increase (decrease) in deferred liabilities for the quarter ending 2016-09-30 was -$7.64K.
- ADMA BIOLOGICS, INC. increase (decrease) in deferred liabilities for the quarter ending 2016-06-30 was -$7.64K.
- ADMA BIOLOGICS, INC. increase (decrease) in deferred liabilities for fiscal 2016 was -$30.56K, a 167.22% decline from fiscal 2015.
- ADMA BIOLOGICS, INC. increase (decrease) in deferred liabilities for fiscal 2015 was $45.46K.
- ADMA BIOLOGICS, INC. increase (decrease) in deferred liabilities for fiscal 2014 was -$22.19K.
- ADMA BIOLOGICS, INC. increase (decrease) in deferred liabilities for fiscal 2013 was -$22.19K.
| Period end | Increase (Decrease) in Deferred Liabilities 3 month | Increase (Decrease) in Deferred Liabilities 6 month | Increase (Decrease) in Deferred Liabilities 9 month | Increase (Decrease) in Deferred Liabilities 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$7.64K 10-Q · filed 2017-05-12 | -$15.28K derived: sum of 2 quarters · filed 2017-05-12 | -$22.92K derived: sum of 3 quarters · filed 2017-05-12 | -$30.56K derived: sum of 4 quarters · filed 2017-05-12 |
| 2016-12-31 | -$7.64K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | -$15.28K derived: sum of 2 quarters · filed 2017-02-24 | -$22.92K derived: sum of 3 quarters · filed 2017-02-24 | -$30.56K 10-K · filed 2017-02-24 |
| 2016-09-30 | -$7.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$15.28K derived: sum of 2 quarters · filed 2016-11-10 | -$22.92K 10-Q · filed 2016-11-10 | -$30.56K derived: sum of 4 quarters · filed 2017-05-12 |
| 2016-06-30 | -$7.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | -$15.28K 10-Q · filed 2016-08-12 | -$22.92K derived: sum of 3 quarters · filed 2017-05-12 | -$30.56K derived: sum of 4 quarters · filed 2017-05-12 |
| 2016-03-31 | -$7.64K 10-Q · filed 2017-05-12 | -$15.28K derived: sum of 2 quarters · filed 2017-05-12 | -$22.92K derived: sum of 3 quarters · filed 2017-05-12 | -$30.56K derived: sum of 4 quarters · filed 2017-05-12 |
| 2015-12-31 | -$7.64K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | -$15.28K derived: sum of 2 quarters · filed 2017-02-24 | -$22.92K derived: sum of 3 quarters · filed 2017-02-24 | $45.46K 10-K · filed 2017-02-24 |
| 2015-09-30 | -$7.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$15.28K derived: sum of 2 quarters · filed 2016-11-10 | $53.10K 10-Q · filed 2016-11-10 | $47.55K derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | -$7.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $60.74K 10-Q · filed 2016-08-12 | $55.20K derived: sum of 3 quarters · filed 2016-08-12 | $49.65K derived: sum of 4 quarters · filed 2016-08-12 |
| 2015-03-31 | $68.38K 10-Q · filed 2016-05-13 | $62.84K derived: sum of 2 quarters · filed 2016-05-13 | $57.29K derived: sum of 3 quarters · filed 2016-05-13 | $51.74K derived: sum of 4 quarters · filed 2016-05-13 |
| 2014-12-31 | -$5.55K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | -$11.10K derived: sum of 2 quarters · filed 2016-03-23 | -$16.64K derived: sum of 3 quarters · filed 2016-03-23 | -$22.19K 10-K · filed 2016-03-23 |
| 2014-09-30 | -$5.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -$11.10K derived: sum of 2 quarters · filed 2015-11-10 | -$16.64K 10-Q · filed 2015-11-10 | -$22.19K derived: sum of 4 quarters · filed 2015-11-10 |
| 2014-06-30 | -$5.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | -$11.10K 10-Q · filed 2015-08-11 | -$16.64K derived: sum of 3 quarters · filed 2015-08-11 | -$22.19K derived: sum of 4 quarters · filed 2015-08-11 |
| 2014-03-31 | -$5.55K 10-Q · filed 2015-05-12 | -$11.10K derived: sum of 2 quarters · filed 2015-05-12 | -$16.64K derived: sum of 3 quarters · filed 2015-05-12 | -$22.19K derived: sum of 4 quarters · filed 2015-05-12 |
| 2013-12-31 | -$5.55K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | -$11.10K derived: sum of 2 quarters · filed 2015-03-09 | -$16.64K derived: sum of 3 quarters · filed 2015-03-09 | -$22.19K 10-K · filed 2015-03-09 |
| 2013-09-30 | -$5.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$11.10K derived: sum of 2 quarters · filed 2014-11-10 | -$16.64K 10-Q · filed 2014-11-10 | -$22.19K derived: sum of 4 quarters · filed 2014-11-10 |
| 2013-06-30 | -$5.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$11.10K 10-Q · filed 2014-08-11 | -$16.64K derived: sum of 3 quarters · filed 2014-08-11 | -$22.19K derived: sum of 4 quarters · filed 2014-08-11 |
| 2013-03-31 | -$5.55K 10-Q · filed 2014-05-12 | -$11.10K derived: sum of 2 quarters · filed 2014-05-12 | -$16.64K derived: sum of 3 quarters · filed 2014-05-12 | -$22.19K derived: sum of 4 quarters · filed 2014-05-12 |
| 2012-12-31 | -$5.55K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | -$11.10K derived: sum of 2 quarters · filed 2014-03-28 | -$16.64K derived: sum of 3 quarters · filed 2014-03-28 | -$22.19K 10-K · filed 2014-03-28 |
| 2012-09-30 | -$5.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$11.10K derived: sum of 2 quarters · filed 2013-11-12 | -$16.64K 10-Q · filed 2013-11-12 | -$22.19K derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-06-30 | -$5.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | -$11.10K 10-Q · filed 2013-08-12 | -$16.64K derived: sum of 3 quarters · filed 2013-08-12 | -$22.19K derived: sum of 4 quarters · filed 2013-08-12 |
| 2012-03-31 | -$5.55K 10-Q · filed 2013-05-14 | -$11.10K derived: sum of 2 quarters · filed 2013-05-14 | -$16.64K derived: sum of 3 quarters · filed 2013-05-14 | -$25.16K derived: sum of 4 quarters · filed 2013-05-14 |
| 2011-12-31 | -$5.55K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-06 | -$11.10K derived: sum of 2 quarters · filed 2013-03-06 | -$19.61K derived: sum of 3 quarters · filed 2013-03-06 | -$22.19K 10-K · filed 2013-03-06 |
| 2011-09-30 | -$5.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | -$14.06K derived: sum of 2 quarters · filed 2012-11-13 | -$16.64K 10-Q · filed 2012-11-13 | |
| 2011-06-30 | -$8.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$11.10K 10-Q · filed 2012-08-14 | ||
| 2011-03-31 | -$2.58K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |